| Karen F Giardino, MD (ENDOCRINOLOGIST) | |
|
5530 Sheridan Dr, 1b, Williamsville, NY 14221-3730 | |
| (716) 636-8357 | |
| (716) 636-1369 |
| Full Name | Karen F Giardino |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 39 Years |
| Location | 5530 Sheridan Dr, Williamsville, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023175361 | NPI | - | NPPES |
| 00010063102 | Other | UNIVERA | |
| 00527094001 | Other | BC BS | |
| 2208588 | Other | INDEPENDENT HEALTH | |
| 00010063102 | Other | UNICARE | |
| 1023175361 | Other | NY | INDIVIDUAL NPI |
| 0005270941 | Other | BC/BS | |
| 01210599 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaleida Health | Buffalo, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| General Physician Pc | 9537213079 | 333 |
News Archive
Doctors across the country are still prescribing higher-dose menopausal hormone therapy pills, despite clinical evidence that low doses and skin patches work just as well and carry fewer health risks. That's what researchers at the Stanford University School of Medicine found in a study that will be published online Dec. 2 in Menopause: The Journal of the North American Menopause Society.
A high cerebral microbleed count increases an individual's risk of cognitive deterioration and dementia, study results indicate.
Several genetic tests are available for Alzheimer's disease, both for the general public and for those with a family history of the disease. As direct-to-consumer testing over the internet rises, so have concerns over how people will handle information related to their risk of developing Alzheimer's disease.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).
› Verified 5 days ago
| Entity Name | Frank R Laurri Md & Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548305519 PECOS PAC ID: 9335114800 Enrollment ID: O20040827001104 |
News Archive
Doctors across the country are still prescribing higher-dose menopausal hormone therapy pills, despite clinical evidence that low doses and skin patches work just as well and carry fewer health risks. That's what researchers at the Stanford University School of Medicine found in a study that will be published online Dec. 2 in Menopause: The Journal of the North American Menopause Society.
A high cerebral microbleed count increases an individual's risk of cognitive deterioration and dementia, study results indicate.
Several genetic tests are available for Alzheimer's disease, both for the general public and for those with a family history of the disease. As direct-to-consumer testing over the internet rises, so have concerns over how people will handle information related to their risk of developing Alzheimer's disease.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).
› Verified 5 days ago
| Entity Name | General Physician Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093959322 PECOS PAC ID: 9537213079 Enrollment ID: O20090818000154 |
News Archive
Doctors across the country are still prescribing higher-dose menopausal hormone therapy pills, despite clinical evidence that low doses and skin patches work just as well and carry fewer health risks. That's what researchers at the Stanford University School of Medicine found in a study that will be published online Dec. 2 in Menopause: The Journal of the North American Menopause Society.
A high cerebral microbleed count increases an individual's risk of cognitive deterioration and dementia, study results indicate.
Several genetic tests are available for Alzheimer's disease, both for the general public and for those with a family history of the disease. As direct-to-consumer testing over the internet rises, so have concerns over how people will handle information related to their risk of developing Alzheimer's disease.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen F Giardino, MD (ENDOCRINOLOGIST) 5530 Sheridan Dr, 1b, Williamsville, NY 14221-3730 Ph: (716) 636-8357 | Karen F Giardino, MD (ENDOCRINOLOGIST) 5530 Sheridan Dr, 1b, Williamsville, NY 14221-3730 Ph: (716) 636-8357 |
News Archive
Doctors across the country are still prescribing higher-dose menopausal hormone therapy pills, despite clinical evidence that low doses and skin patches work just as well and carry fewer health risks. That's what researchers at the Stanford University School of Medicine found in a study that will be published online Dec. 2 in Menopause: The Journal of the North American Menopause Society.
A high cerebral microbleed count increases an individual's risk of cognitive deterioration and dementia, study results indicate.
Several genetic tests are available for Alzheimer's disease, both for the general public and for those with a family history of the disease. As direct-to-consumer testing over the internet rises, so have concerns over how people will handle information related to their risk of developing Alzheimer's disease.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).
› Verified 5 days ago
Maria Kontos, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 325 Essjay Rd, Williamsville, NY 14221 Phone: 716-656-4463 | |
Dr. Anderson Ka Ho Lai, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1540 Maple Rd, Williamsville, NY 14221 Phone: 716-568-3514 | |
Colleen Klos, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1540 Maple Rd, Williamsville, NY 14221 Phone: 716-568-3514 | |
Dawn Patricia Hrab, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1835 Maple Rd, Williamsville, NY 14221 Phone: 716-634-5410 Fax: 716-634-0430 | |
Cheri A Gorski-suhr, RPAC Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 825 Wehrle Drive, Cardiology Group Of Western New York,pc, Williamsville, NY 14221 Phone: 716-634-3243 Fax: 716-634-1930 | |
Yijun Cheng, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 295 Essjay Rd, Williamsville, NY 14221 Phone: 716-630-1048 | |
Mr. Martin Neal Mango, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1825 Maple Rd, Williamsville, NY 14221 Phone: 716-631-0834 Fax: 716-631-0880 |